Aurinia Pharmaceuticals Inc.

AUPH

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001600620

SEC filings (opens in a new tab)

In the last 90 days, Aurinia Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 282 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Aurinia Pharmaceuticals Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of AUPH: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	171	3	183	+15
Shares	56.0M	9.27M	58.5M	+11.8M (+25.2%)
Value	$319.9M	$53.0M	$428.9M	+$161.9M (+60.6%)

3 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (31)

Institutions that held Aurinia Pharmaceuticals Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to AUPH in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	9,065,931	$66.5M	0.00%
Connor, Clark & Lunn Investment Management Ltd.	454,259	$3.33M	0.02%
Group One Trading, L.P.	350,413	$2.57M	0.10%
IFP Advisors, Inc	207,025	$1.52M	0.05%
Wolverine Trading, LLC	206,099	$1.50M	0.04%
Jump Financial, LLC	189,955	$1.39M	0.03%
Man Group plc	99,371	$728.4K	0.00%
American Century Companies Inc	76,524	$560.9K	0.00%
Schonfeld Strategic Advisors LLC	58,500	$428.8K	0.00%
Intech Investment Management LLC	35,718	$261.8K	0.00%
Teza Capital Management LLC	28,452	$208.6K	0.02%
Jefferies Financial Group Inc.	26,590	$194.9K	0.00%
Sherbrooke Park Advisers LLC	25,392	$186.1K	0.04%
EntryPoint Capital, LLC	24,230	$177.6K	0.10%
Cubist Systematic Strategies, LLC	20,409	$149.6K	0.00%
Western Wealth Management, LLC	20,000	$146.6K	0.01%
Bridgefront Capital, LLC	14,715	$107.9K	0.04%
O'Shaughnessy Asset Management, LLC	14,274	$101.6K	0.00%
Engineers Gate Manager LP	10,520	$77.1K	0.00%
Acadian Asset Management LLC	8,732	$64.0K	0.00%
Catalyst Funds Management Pty Ltd	5,200	$38.1K	0.01%
nVerses Capital, LLC	2,400	$17.6K	0.01%
Capital Performance Advisors LLP	1,181	$8.66K	0.00%
Golden State Equity Partners	900	$6.60K	0.00%
True Wealth Design, LLC	468	$3.43K	0.00%
Smartleaf Asset Management LLC	468	$3.41K	0.00%
Truvestments Capital LLC	437	$3.20K	0.00%
Spectrum Wealth Counsel, LLC	334	$2.45K	0.00%
Bessemer Group Inc	215	$2.00K	0.00%
Sterling Capital Management LLC	219	$1.60K	0.00%
Ronald Blue Trust, Inc.	203	$1.16K	0.00%

Sold out (16)

Institutions that held Aurinia Pharmaceuticals Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of AUPH in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Schroder Investment Management Group	997,221	$5.69M
683 Capital Management, LLC	400,000	$2.28M
Stonepine Capital Management, LLC	300,000	$1.71M
Jupiter Asset Management Ltd	158,497	$905.0K
Vontobel Holding Ltd.	80,000	$456.8K
AlphaCentric Advisors LLC	80,000	$456.8K
Virtu Financial LLC	54,102	$309.0K
Fox Run Management, L.L.C.	28,797	$164.4K
Campbell & CO Investment Adviser LLC	19,597	$111.9K
Stifel Financial Corp	17,064	$97.4K
Daymark Wealth Partners, LLC	10,000	$57.1K
Caption Management, LLC	6,076	$34.7K
Optiver Holding B.V.	1,785	$10.2K
Jones Financial Companies LLLP	700	$4.00K
Allspring Global Investments Holdings, LLC	595	$3.40K
NBC Securities, Inc.	600	$3.00K

Not filed for Q3 2024 yet (3)

Institutions that held Aurinia Pharmaceuticals Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AUPH in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	9,272,162	$52.9M
Benjamin F. Edwards & Company, Inc.	1,130	$6.00K
Spotlight Asset Group, Inc.	75	$428